Keywords
Clinical Trial ×
Pulmonary Disease, Chronic Obstructive ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

- 7/29/20 - 1 form, 16 itemgroups, 59 items, 1 language
Itemgroups: Administrative, Non-serious Adverse Events (AE), Non-serious Adverse Events (AE) , Serious Adverse Event (SAE), Serious Adverse Event (SAE) - Section 1, Serious Adverse Event (SAE) - Section 2 Seriousness, Serious Adverse Event (SAE) - Section 3 Demography Data, Serious Adverse Event (SAE) - Section 4, Serious Adverse Event (SAE) - Section 5 , Serious Adverse Event (SAE) - Section 6 Relevant Medical Conditions, Serious Adverse Event (SAE) - Section 7 Other relevant risk factors, Serious Adverse Event (SAE) - Section 8 Concomitant medications , Serious Adverse Event (SAE) - Section 9 Details of investigational product(s), Serious Adverse Event (SAE) - Section 10, Serious Adverse Event (SAE) - Section 11 Narrative remarks, Investigator's signature
- 7/25/20 - 1 form, 7 itemgroups, 32 items, 1 language
Itemgroups: Administrative, Pulmonary Function Tests, Pulmonary Function Tests - Investigator Calculation, Pulmonary Function Tests (Plethysmography Pre-Ipratropium Bromide), Ipratropium Bromide Administration, Pulmonary Function Tests (Plethysmography Post-Ipratropium Bromide), Pulmonary Function Tests (Plethysmography Post-Ipratropium Bromide) - Investigator Calculation